Relay Therapeutics Inc
RLAY · NASDAQ
Relay Therapeutics, Inc. operates as a biotechnology company. The Company develops durgs for the treatment of cancer. Relay Therapeutics serves customers in the United States.
ESG Scores
Overall ESG5.0
Environmental6.6
Social4.2
Governance4.8
Gender Diversity
Female Directors0.375%
Women in Workforce0.43700000000000006%
CEO GenderMale